Quarterly Call Option Transactions in Sage Therapeutics, Inc. (SAGE)
This table provides information about the institutional ownership of Sage Therapeutics, Inc. (SAGE) during . The information is specifically focused on institutions that hold call options of Sage Therapeutics, Inc..
Calls Purchased
Calls Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 7,600 | 10,110 | 17,710 | 301,400 | 359,600 | 661,000 | -643,290 | |
Q4 2021 | 331,800 | 683,800 | 1,015,600 | 20,500 | 24,300 | 44,800 | 970,800 | |
Q1 2022 | 300,000 | 37,000 | 337,000 | 334,300 | 0 | 334,300 | 2,700 | |
Q2 2022 | 53,600 | 0 | 53,600 | 1,300 | 6,300 | 7,600 | 46,000 | |
Q3 2022 | 98,800 | 109,600 | 208,400 | 1,500 | 0 | 1,500 | 206,900 | |
Q4 2022 | 48,700 | 95,100 | 143,800 | 59,900 | 0 | 59,900 | 83,900 | |
Q1 2023 | 82,500 | 30,000 | 112,500 | 176,800 | 0 | 176,800 | -64,300 | |
Q2 2023 | 19,600 | 99,700 | 119,300 | 36,600 | 0 | 36,600 | 82,700 | |
Q3 2023 | 287,400 | 49,300 | 336,700 | 37,700 | 0 | 37,700 | 299,000 | |
Q4 2023 | 147,600 | 41,600 | 189,200 | 251,500 | 0 | 251,500 | -62,300 | |
Q1 2024 | 3,000 | 0 | 3,000 | 208,500 | 0 | 208,500 | -205,500 | |
Q2 2024 | 180,400 | 520,200 | 700,600 | 21,800 | 0 | 21,800 | 678,800 | |
Q3 2024 | 76,900 | 28,600 | 105,500 | 23,700 | 0 | 23,700 | 81,800 |